Multiple immune and tissue cell receptors

The term "Multiple immune and tissue cell receptors" is a non-specific, collective designation rather than a single, well-defined therapeutic target (Nature Reviews Drug Discovery, 2007). It refers to a broad array of proteins located on the surfaces of various immune system cells—such as T-cells, B-cells, and macrophages—and structural tissue cells that mediate cellular signaling, adhesion, and environmental sensing (NIH, National Cancer Institute). Because this term encompasses a wide variety of molecular classes, including G protein-coupled receptors (GPCRs), cytokine receptors, and integrins, it does not allow for the precise characterization of a drug's mechanism of action or safety profile (UniProt). In modern drug development, targeting multiple receptors is a common strategy employed by multi-specific antibodies or broad-spectrum small molecules to overcome disease redundancy or resistance, particularly in complex conditions like oncology and autoimmune disorders (Nature Reviews Drug Discovery, 2014). However, for regulatory and clinical purposes, specific targets within this group must be identified individually to understand their unique roles in disease and their interactions with therapeutic agents. Consequently, this entry is considered a descriptive category rather than a distinct, actionable molecular target.

Not applicable as this is a non-specific descriptive term rather than a single molecular target.